Assessment of the potential diagnostic value of serum p53 antibody for cancer: A meta-analysis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zhang, Jun ^a   Xu, Zhiwei ^b   Yu, Lingxiang ^b   Chen, Meilan ^a   Li, Ke ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; P53 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; PROTEIN P53; TUMOR MARKER;

AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CLASSIFICATION; CANCER PATIENT; COLORECTAL CANCER; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ESOPHAGUS CANCER; GENETIC HETEROGENEITY; HEAD AND NECK CANCER; HUMAN; LIVER CANCER; LUNG CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; OVARY CANCER; PANCREAS CANCER; PREDICTIVE VALUE; PROSTATE CANCER; PUBLISHING; QUALITY ASSESSMENT OF STUDIES OF DIAGNOSTIC ACCURACY SCORE; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SUMMARY RECEIVER OPERATING CHARACTERISTIC CURVE; SYSTEMATIC REVIEW; BLOOD; GENETICS; IMMUNOLOGY; META ANALYSIS; MUTATION; NEOPLASMS; PROGNOSIS; REPRODUCIBILITY; RISK;

ANTIBODIES; HUMANS; MUTATION; NEOPLASMS; ODDS RATIO; PROGNOSIS; PUBLICATION BIAS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84902651469     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099255     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM (2010) The global burden of cancer: priorities for prevention. Carcinogenesis 31: 100-110.
3. Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends in Genetics 9: 138-141. (Pubitemid 23098782)
4. Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351: 453-456. (Pubitemid 21896613)
5. Wu M, Mao C, Chen Q, Cu XW, Zhang WS (2010) Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls. Mol Biol Rep 37: 339-343.
6. Li L, Wang K, Dai L, Wang P, Peng X-X, et al. (2008) Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer. Molecular medicine reports 1: 589.
7. Smidt N, Deeks J, Moore T (2011) Guide to the contents of a Cochrane review and protocol. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy.
8. Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, et al. (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2: 9.
9. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled clinical trials 7: 177-188. (Pubitemid 17189972)
10. Gallagher EJ (1998) Clinical utility of likelihood ratios. Ann Emerg Med 31: 391-397.
11. Honest H, Khan K (2002) Reporting of measures of accuracy in systematic reviews of diagnostic literature. BMC health services research 2: 4.
12. Gu P, Huang G, Chen Y, Zhu C, Yuan J, et al. (2007) Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis. J Clin Lab Anal 21: 398-405. (Pubitemid 350250409)
13. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129-1135. (Pubitemid 37386338)
14. Lijmer JG, Bossuyt PM, Heisterkamp SH (2002) Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 21: 1525-1537. (Pubitemid 34746061)
15. Walter SD (2002) Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21: 1237-1256.
16. Jones CM, Athanasiou T (2005) Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 79: 16-20. (Pubitemid 40037431)
17. Dinnes J, Deeks J, Kirby J, Roderick P (2005) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technology Assessment 9: 1-113.
18. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
19. Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58: 882-893. (Pubitemid 41115772)
20. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6: 31.
21. Moses LE, Shapiro D, Littenberg B (2007) Combining independent studies of a diagnostic test into a summary roc curve: Data-analytic approaches and some additional considerations. Stat Med 12: 1293-1316.
22. Zhang J, Xv Z, Wu X, Li K (2012) Potential diagnostic value of serum p53 antibody for detecting esophageal cancer: a meta-analysis. PLoS One 7: e52896.
23. Lubin R, Zalcman G, Bouchet L, Tredanel J, Legros Y, et al. (1995) Serum p53 antibodies as early markers of lung cancer. Nat Med 1: 701-702.
24. Trivers GE, Cawley HL, DeBenedetti VM, Hollstein M, Marion MJ, et al. (1995) Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst 87: 1400-1407.
25. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25.
26. Khan KS, ter Riet G, Glanville J, Sowden AJ, Kleijnen J (2001) Undertaking systematic reviews of research on effectiveness: CRD's guidance for carrying out or commissioning reviews: NHS Centre for Reviews and Dissemination.
27. Clarke M, Oxman A (2003) Cochrane reviewers' handbook 4.2. 0 [updated March 2003]. The Cochrane Library 2.
28. Dickersin K, Scherer R, Lefebvre C (1994) Identifying relevant studies for systematic reviews. BMJ: British Medical Journal 309: 1286.